Reply to ‘A phase
II
randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’
2017 ◽
Vol 176
(2)
◽
pp. 551-552
◽
2016 ◽
Vol 175
(5)
◽
pp. 1073-1075
◽
2017 ◽
Vol 176
(2)
◽
pp. 552-553
◽
2012 ◽
Vol 12
(5)
◽
pp. 1146-1156
◽
2017 ◽
Vol 17
(6)
◽
pp. 1594-1605
◽
2004 ◽
Vol 77
(2)
◽
pp. 206-209
◽